Thermo Fisher Scientific (TMO) said Tuesday that it has agreed to acquire Solventum's (SOLV) Purification & Filtration business for $4.1 billion in cash.
Thermo said the deal, which is set to be completed by the end of the year, is expected to be dilutive to adjusted EPS by $0.06.
In a separate statement, Solventum said it expects the deal to be neutral to EPS this year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。